Betsholtz C, Heldin C H, Nister M, Ek B, Wasteson A, Westermark B
Biochem Biophys Res Commun. 1983 Nov 30;117(1):176-82. doi: 10.1016/0006-291x(83)91557-7.
Several human normal and neoplastic cell lines were screened for production of PDGF receptor competing activity. Conditioned medium from two sarcomas and one glioma blocked 125I-PDGF binding to human foreskin fibroblasts in a dose-dependent manner. In each case this effect was abolished when the conditioned medium was pretreated with PDGF-antiserum, indicating that the receptor competing activity was immunologically related to PDGF. Direct evidence for de novo synthesis of a PDGF-like component in the cultures was afforded by 35S-cysteine labeling of the three cell lines, followed by immunoprecipitation with PDGF antiserum. This resulted in the specific precipitation of a 31,000 molecular weight labeled protein, which upon reduction was split into two polypeptides of molecular weights 17,000 and 16,500. The significance of these findings in view of the recently discovered structure homology between PDGF and the transforming gene product of simian sarcoma virus, p28sis, is discussed.
对几种人类正常细胞系和肿瘤细胞系进行了筛选,以检测其是否产生血小板源性生长因子(PDGF)受体竞争活性。来自两种肉瘤和一种神经胶质瘤的条件培养基以剂量依赖方式阻断了125I-PDGF与人包皮成纤维细胞的结合。在每种情况下,当用PDGF抗血清预处理条件培养基时,这种效应就会消失,这表明受体竞争活性在免疫学上与PDGF相关。通过对这三种细胞系进行35S-半胱氨酸标记,然后用PDGF抗血清进行免疫沉淀,为培养物中从头合成PDGF样成分提供了直接证据。这导致特异性沉淀出一种分子量为31,000的标记蛋白,该蛋白在还原后被裂解为分子量分别为17,000和16,500的两种多肽。鉴于最近发现的PDGF与猿猴肉瘤病毒的转化基因产物p28sis之间的结构同源性,讨论了这些发现的意义。